| Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$652 |
Update - Notification regarding unquoted securities - IMR
|
21 May 2026 9:33AM |
$1.775 |
$1.845 |
risen by
3.94%
|
|
| Great Dirt Resources Limited (GR8) ORDINARY FULLY PAID |
Materials |
$31 |
Application for quotation of securities - GR8
|
21 May 2026 9:32AM |
$0.760 |
$0.620 |
fallen by
18.42%
|
|
| Nutritional Growth Solutions Ltd (NGS) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Trading Halt
|
21 May 2026 9:31AM |
$0.020 |
$0.022 |
risen by
10%
|
|
NGS - Price-sensitive ASX Announcement
Full Release
Key Points
- Nutritional Growth Solutions Ltd (ASX: NGS) has requested a trading halt.
- The purpose of the trading halt is related to a proposed acquisition and associated capital raise.
- The trading halt is necessary for NGS to manage its continuous disclosure obligations.
- Trading will halt until either an announcement is made or normal trading resumes on 25 May 2026.
- The company expects to make an announcement before the commencement of normal trading on 25 May 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Energy One Limited (EOL) ORDINARY FULLY PAID |
Information Technology |
$382 |
May Market Update
|
21 May 2026 9:31AM |
$13.650 |
$12.140 |
fallen by
11.06%
|
|
EOL - Price-sensitive ASX Announcement
Full Release
Key Points
- Structural complexity in energy markets increases demand for EOL's services.
- Ben Tranier took over as CEO in March 2026.
- Sales pipeline is growing, with strong engagement from Tier 1 customers.
- CEO transition complete; Shaun Ankers transitions to Non-Executive Director role.
- Projected ARR growth of 13% for FY26, slightly below projections due to timing of project commencements.
- New initiatives focus on product portfolio direction and AI integration.
- Strategic acquisition opportunities are under review.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GR Engineering Services Limited (GNG) ORDINARY FULLY PAID |
Materials |
$972 |
EPC Contract - Tower Hill Project
|
21 May 2026 9:30AM |
$4.820 |
$5.710 |
risen by
18.46%
|
|
GNG - Price-sensitive ASX Announcement
Full Release
Key Points
- GR Engineering Services Limited announced the execution of an EPC contract.
- The contract is with Genesis Minerals (Leonora) Pty Ltd for the Tower Hill Gold Project.
- GR Engineering was previously appointed as the Preferred Contractor for this project.
- The contract sum is $229 million.
- The project involves a 3.5-4.0Mtpa Tower Hill Gold Project.
- The announcement highlights GR Engineering's track record in successful project delivery.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Genesis Minerals Limited (GMD) ORDINARY FULLY PAID |
Materials |
$6,980 |
GNG: EPC Contract - Tower Hill Project
|
21 May 2026 9:30AM |
$5.800 |
$6.110 |
risen by
5.34%
|
|
| Staude Capital Global Value Fund Limited (GVF) ORDINARY FULLY PAID |
Financials |
$274 |
Application for quotation of securities - GVF
|
21 May 2026 9:29AM |
$1.320 |
$1.350 |
risen by
2.27%
|
|
| Little Green Pharma Ltd (LGP) ORDINARY FULLY PAID |
Health Care |
$63 |
Corporate Governance Statement and Appendix 4G
|
21 May 2026 9:29AM |
$0.100 |
$0.077 |
fallen by
23%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,409 |
TOV: ALX - Panel Declines to Make Declaration
|
21 May 2026 9:29AM |
$4.810 |
$5.105 |
risen by
6.13%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Panel declined to make a declaration of unacceptable circumstances.
- Diamond Infraco 1 Pty Ltd launched an off-market takeover bid for Atlas Arteria.
- The offer price was set to increase if a 45% interest threshold was reached.
- ASIC relief provided to extend the offer period if conditions met.
- DICO undertook not to exercise certain discretions without Panel's consent.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ClearVue Technologies Limited (CPV) ORDINARY FULLY PAID |
Industrials |
$34 |
CPV Secures A$305,000 Commercial Retrofit Project in Cyprus
|
21 May 2026 9:28AM |
$0.110 |
$0.110 |
fallen by
0%
|
|
CPV - Price-sensitive ASX Announcement
Full Release
Key Points
- ClearVue secures A$305,000 contract for BIPV glazing in Cyprus.
- Project involves 800m²+ solar façade for Rio Business Centre.
- Estimated annual electricity generation of ~139 MWh.
- ClearVue's products selected for advanced engineering features.
- BIPV integration supports sustainable and energy-efficient design.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lion Selection Group Limited (LSX) ORDINARY FULLY PAID |
Financials |
$123 |
Quarterly Report for 3 months ended 30 April 2026
|
21 May 2026 9:27AM |
$0.845 |
$0.860 |
risen by
1.78%
|
|
| Nex Metals Exploration Limited (NME) ORDINARY FULLY PAID |
Materials |
$5 |
NME and WTAC form Gold Exploration JV
|
21 May 2026 9:27AM |
$0.019 |
$0.014 |
fallen by
26.32%
|
|
NME - Price-sensitive ASX Announcement
Full Release
Key Points
- WTAC owns 60% of the joint venture and provides all funding.
- NME owns 40% of the joint venture, focusing on project identification and management.
- The joint venture aims to develop gold mining opportunities in Western Australia.
- Jason Livingstone appointed to lead the joint venture's operations.
- WTAC Commercial Services is a preferred provider for the joint venture.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Locksley Resources Limited (LKY) ORDINARY FULLY PAID |
Materials |
$28 |
High-Grade Antimony Intervals Intersected at DAM
|
21 May 2026 9:27AM |
$0.120 |
$0.075 |
fallen by
37.50%
|
|
LKY - Price-sensitive ASX Announcement
Full Release
Key Points
- Maiden drilling at DAM confirmed high-grade antimony mineralisation below historic underground workings.
- The drilling intersected subvertical quartz-stibnite veins within granite gneiss and tonalite.
- Hole DADD0005A showed 4.0 metres grading 4.87% Sb, including an interval of 0.4 metres at 33.51% Sb.
- Hole DADD0004 returned an intercept of 1.4 metres grading 5.62% Sb.
- Locklsey believes results suggest a larger hydrothermal antimony system.
- Further work will focus on refining structural controls and ongoing targeting.
- The project aims at re-establishing domestic antimony supply chains in the U.S.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kuniko Limited (KNI) ORDINARY FULLY PAID |
Materials |
$6 |
High-Grade Gold & Silver at Commonwealth-Silica Hill
|
21 May 2026 9:26AM |
$0.035 |
$0.028 |
fallen by
20%
|
|
KNI - Price-sensitive ASX Announcement
Full Release
Key Points
- Kuniko Limited completed a successful Phase 1 diamond drilling program at Commonwealth-Silica Hill.
- High-grade gold and silver mineralisation was confirmed at Commonwealth Main and South.
- Drillhole CMKNI006 intersected 7.1m at 8.4 g/t Au and 42 g/t Ag, indicating continuity of high-grade mineralisation.
- Phase 2 drilling program to begin in early July with a focus on larger extensions and deeper targets.
- Geophysical consultants conducting regional targeting review for new discoveries.
- Commonwealth Project is part of the prolific Lachlan Fold Belt, a Tier-1 mining region.
- The project comprises Commonwealth Main and Silica Hill deposits, both of which show significant exploration potential.
- Kuniko is in a binding earn-in and JV agreement with Impact Minerals to earn up to 70% of the project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Midas Minerals Ltd (MM1) ORDINARY FULLY PAID |
Materials |
$236 |
Further Exceptional Copper and Silver Intercepts, Otavi
|
21 May 2026 9:26AM |
$0.890 |
$0.980 |
risen by
10.11%
|
|
MM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Midas Minerals Ltd reported further significant copper and silver intercepts at T-13 Deposit.
- Assay results were received for six infill holes on the T-13 Copper-Silver Deposit at Otavi Copper Project.
- Significant intercepts include 46.2m at 4.01% CuEq and 50.6m at 7.81% CuEq.
- The company operates five rigs with plans to add another at Otavi.
- Midas plans an MRE update for T-13 in 2026.
- Namibia is a favorable mining jurisdiction due to stable democracy and infrastructure.
- Midas holds options to acquire interests in several projects around Otavi.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$108 |
Island Adds Biodefence Leader as Filovirus Risks Escalate
|
21 May 2026 9:25AM |
$0.400 |
$0.365 |
fallen by
8.75%
|
|
ILA - Price-sensitive ASX Announcement
Full Release
Key Points
- Raymond Taylor appointed to drive Galidesivir development.
- Taylor has over 40 years of experience in drug development and biodefense.
- Galidesivir is a broad-spectrum antiviral targeting multiple high-consequence viruses.
- Taylor's appointment strengthens Island's US Government engagement capabilities.
- Galidesivir shows promise in Marburg and Ebola non-human primate studies.
- Existing US Strategic National Stockpile countermeasures are strain-specific, unlike Galidesivir.
- Appointment comes amid rising global concern over Ebola and related filoviruses.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$3,913 |
Update - Notification of buy-back - AMP
|
21 May 2026 9:25AM |
$1.570 |
$1.583 |
risen by
0.80%
|
|
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$14 |
Rights Issue Offer Document
|
21 May 2026 9:24AM |
$0.013 |
$0.016 |
risen by
23.08%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- Offer document for a renounceable rights offer.
- Targets shareholders in New Zealand and Australia.
- Offer period: May 29, 2026, to June 17, 2026.
- Rights will not be quoted on NZX or ASX.
- Eligible shareholders can apply for shortfall shares.
- Issue price: NZ$0.013 or A$0.011 per share.
- Offer is governed by New Zealand law.
- Part of TruScreen's market expansion efforts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$14 |
Cleansing Notice
|
21 May 2026 9:23AM |
$0.013 |
$0.016 |
risen by
23.08%
|
|
| Bougainville Copper Limited (BOC) 1 KINA ORDINARY FULLY PAID |
Materials |
$88 |
Reinstatement to Quotation
|
21 May 2026 9:23AM |
$0.635 |
$0.220 |
fallen by
65.35%
|
|
BOC - Price-sensitive ASX Announcement
Full Release
Key Points
- Bougainville Copper Limited's (BOC) securities will resume trading.
- Suspension lifted following the lodgement of BOC's Annual Report.
- Reinstatement of trading effective from 21 May 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bougainville Copper Limited (BOC) 1 KINA ORDINARY FULLY PAID |
Materials |
$88 |
2025 Annual Report to shareholders
|
21 May 2026 9:23AM |
$0.635 |
$0.220 |
fallen by
65.35%
|
|
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$14 |
Corporate Action Notice
|
21 May 2026 9:21AM |
$0.013 |
$0.016 |
risen by
23.08%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- Truscreen Group Limited announced a corporate action involving a placement and bonus issue.
- The rights issue will include 149,465,065 rights with an entitlement ratio of 1 new for every 5 existing shares.
- Subscription price per equity security is NZ$0.013/A$0.011.
- The placement includes up to 71,428,571 equity securities at NZ$0.014/A$0.012 per security.
- Existing holders and related parties may participate, subject to shareholder approval.
- Purpose of issuance includes MDR compliance, African market registrations, and clinical evidence development.
- Lead Managers for the placement are SP Corporate Pty Ltd and Erity Capital Pty Ltd, with associated fees and broker options.
- Oversubscription is at the Directors' discretion and subject to shareholder approval.
- The placement aims to access a broader pool of investors and offers favorable pricing.
- Corporate action is aligned with NZX Listing Rule 4.2 and requires external approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$14 |
Option Extension Prospectus
|
21 May 2026 9:21AM |
$0.013 |
$0.016 |
risen by
23.08%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- TruScreen Group Limited is extending the expiry date of its existing options by offering new extended options.
- The offers include Extended Placement Options, Extended SPP Options, and Extended Broker Options.
- Each extended option has an exercise price of NZ$0.022 (A$0.02) and will expire on 17 July 2027.
- The offers are made to Australian Placement Optionholders, Australian SPP Optionholders, and the Joint Lead Managers.
- The company will not apply for quotation of the options on NZX or ASX.
- The offers are not expected to materially affect the control of the company.
- The offers are being made as a varied offer under the Financial Markets Conduct Act 2013 (NZ).
- The document serves as a transaction-specific prospectus as per Australian regulations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Global Long Short Fund Limited (GLS) ORDINARY FULLY PAID |
Financials |
$1,068 |
Change of Auditor
|
21 May 2026 9:19AM |
$1.770 |
$1.950 |
risen by
10.17%
|
|
| Prodigy Gold NL (PRX) ORDINARY FULLY PAID |
Materials |
$22 |
Board Changes
|
21 May 2026 9:19AM |
$0.075 |
$0.064 |
fallen by
14.67%
|
|
Call 1300 880 160
Start a chat
Schedule a call
